Mar 24, 2026 You have probably heard that tirzepatide causes headaches
Most experts recommend taking them indefinitely, the same way people do blood pressure medication
CLINICAL PRACTICE CONSIDERATIONS Long-term outcomes While strong evidence supports the kidney-protective effects of both SGLT2 inhibitors and GLP-1 receptor agonists, the long-term durability of these benefits remains uncertain (Table 2)
Instead of developing healthy habits and lifestyles, this particular group might abuse GLP-1s. Most studies on GLP-1s have been conducted on adult participants, so the information available regarding benefits, such as blood sugar control and weight loss, and the cons, such as weight gain with discontinuation, also apply to those in this age group
Additionally, GLP-1 promotes feelings of fullness, which can lead to a decrease in caloric intake and potential weight loss
According to a 2026 paper, faster is not always better